Africa: Low Donor Numbers Hamper Africa's National Blood Services
[WHO-AFRO] Accra -- A terrible car accident in late 2022 in Ghana's southern Akuse town left Nana Serwaa Brakatuo in a critical condition. With a ruptured liver and blood clots in the lungs, doctors said her chances of survival were bleak, without timely and sufficient blood transfusion needed for her surgery. But thanks to blood donations from anonymous donors, family and friends, doctors were able to save her life. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - June 15, 2023 Category: African Health Tags: Africa External Relations Health and Medicine International Organizations and Africa Source Type: news
Message from Dr Ahmed Al-Mandhari, WHO Regional Director, on the occasion of World Blood Donor ...
Every year on 14 June, countries around the world celebrate World Blood Donor Day. This year’s campaign focuses on patients requiring life-long support with blood transfusion or plasma proteins. The campaign highlights the role that every single person can play, by giving the valuable gift of blood or plasma regularly to ensure a safe and sustainable supply of blood and blood products for all those in need.
Access to a secure blood supply based on voluntary unpaid donation is vital for all patients, including many requiring life-long and regular transfusions for conditions such as sickle-cell anaemia and thalassaemia. I...
Source: WHO EMRO News - June 13, 2023 Category: Middle East Health Source Type: news
New data show Roche ’s subcutaneously administered crovalimab achieved disease control and was well-tolerated in people with paroxysmal nocturnal haemoglobinuria (PNH)
The COMMODORE 2 study demonstrated that subcutaneous crovalimab every four weeks was non-inferior to intravenous eculizumab every two weeks, with comparable safety, in people new to C5 inhibitors1Monthly self-administration of subcutaneous crovalimab has the potential to address the high burden of a disease that requires lifelong treatment including in settings where access to currentC5 inhibitors is limited1,2The COMMODORE 1 study in people switching from currently approved C5 inhibitors supported the consistent benefit-risk profile of crovalimab as seen in the COMMODORE 2 study3Basel, 09 June 2023 - Roche (SIX: RO, ROG; ...
Source: Roche Media News - June 9, 2023 Category: Pharmaceuticals Source Type: news
New data show Roche ’s subcutaneously administered crovalimab achieved disease control and was well-tolerated in people with paroxysmal nocturnal haemoglobinuria (PNH)
The COMMODORE 2 study demonstrated that subcutaneous crovalimab every four weeks was non-inferior to intravenous eculizumab every two weeks, with comparable safety, in people new to C5 inhibitors1Monthly self-administration of subcutaneous crovalimab has the potential to address the high burden of a disease that requires lifelong treatment including in settings where access to currentC5 inhibitors is limited1,2The COMMODORE 1 study in people switching from currently approved C5 inhibitors supported the consistent benefit-risk profile of crovalimab as seen in the COMMODORE 2 study3Basel, 09 June 2023 - Roche (SIX: RO, ROG; ...
Source: Roche Investor Update - June 9, 2023 Category: Pharmaceuticals Source Type: news
Janssen Submits New Drug Application to U.S. FDA Seeking Approval of Investigational Single Tablet Combination Therapy of Macitentan and Tadalafil for Treatment of Patients with Pulmonary Arterial Hypertension (PAH)
RARITAN, NJ, May 30, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval of an investigational single tablet combination therapy of macitentan 10mg and tadalafil 40mg (M/T STCT) for the long-term treatment of pulmonary arterial hypertension (PAH, World Health Organization [WHO] Group 1) in adult patients with WHO functional class (FC) II-III.[1] The application is based on positive data from the Phase 3 A DUE study, which met its primary endpoint and demonstrated that M/T STCT si...
Source: Johnson and Johnson - May 30, 2023 Category: Pharmaceuticals Source Type: news
Why So Many Black Women Die in Pregnancy
BIRMINGHAM — Angelica Lyons knew it was dangerous for Black women to give birth in America.
As a public health instructor, she taught college students about racial health disparities, including the fact that Black women in the U.S. are nearly three times more likely to die during pregnancy or delivery than any other race. Her home state of Alabama has the third-highest maternal mortality rate in the nation.
Then, in 2019, it nearly happened to her.
What should have been a joyous first pregnancy quickly turned into a nightmare when she began to suffer debilitating stomach pain.
[time-brightcove not-tgx=”trueR...
Source: TIME: Health - May 23, 2023 Category: Consumer Health News Authors: Kat Stafford / AP Tags: Uncategorized Public Health wire Source Type: news
Janssen to Highlight Scientific Advances and Commitment to Transform Cancer Care at ASCO and EHA with More than 90 Presentations Showcasing Robust, Differentiated Portfolio and Pipeline in Hematologic Malignancies and Solid Tumors
This study evaluates an investigational combination regimen of IMBRUVICA® (ibrutinib) plus venetoclax (I+V) for newly diagnosed chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL), (Abstracts #7535 and #P617, respectively).Advancing the Science of Solid Tumors Through Precision MedicineJanssen’s continued innovation in solid tumors focuses on advancing precision medicine options for patients with biomarker-driven disease who have limited targeted treatment options and moving patients into earlier lines of therapy when treatments may be more effective. Lung CancerAn oral presentation will report ...
Source: Johnson and Johnson - May 18, 2023 Category: Pharmaceuticals Tags: Innovation Source Type: news
'My baby battled leukaemia thanks to kindness of forty life-saving blood donors'
EXCLUSIVE: A mother whose daughter fought a rare cancer has thanked the 40 people who saved her life with blood transfusions. (Source: Daily Express - Health)
Source: Daily Express - Health - May 1, 2023 Category: Consumer Health News Source Type: news
Drug may not prevent dangerously heavy bleeding after Cesarean delivery
Tranexamic acid didn ’t reduce maternal deaths or the need for blood transfusions in those undergoing either scheduled or emergency Cesarean delivery. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - April 25, 2023 Category: Consumer Health News Source Type: news
Regional Director statement on attacks on health care in Sudan
Cairo, Egypt, 18 April 2023 – WHO strongly condemns reported attacks on health personnel, health facilities, and ambulances in Sudan. These attacks, which appear to be increasing in number, have already led to at least three people killed and two injured. Moreover, they limit access to live saving health care, putting more lives at risk.
Reports of military strikes against health facilities, hijacking of ambulances while patients and paramedics are on board, looting of health facilities, and military forces occupying health facilities are deeply concerning.
Attacks on health care are a flagrant violation of intern...
Source: WHO EMRO News - April 18, 2023 Category: Middle East Health Source Type: news
WHO calls for protection of health workers and patients, unrestricted access to health care in Sudan
16 April 2023 – As fighting continues in Khartoum and other parts of Sudan, the World Health Organization urges all parties to the conflict to respect the neutrality of health care and ensure unrestricted access to health facilities for those injured by the hostilities.
WHO reminds all parties of their obligations under International Humanitarian Law to protect the wounded and sick, civilians, health care workers, ambulances and health facilities.
Since 13 April, more than 83 people have been killed and more than 1126 people injured across Khartoum, South Kordofan, North Darfur, Northern State and other regions, w...
Source: WHO EMRO News - April 16, 2023 Category: Middle East Health Source Type: news
WHO calls for protection of health workers and patients and unrestricted access to health care ...
16 April 2023 – As fighting continues in Khartoum and other parts of Sudan, the World Health Organization urges all parties to the conflict to respect the neutrality of health care and ensure unrestricted access to health facilities for those injured by the hostilities.
WHO reminds all parties of their obligations under International Humanitarian Law to protect the wounded and sick, civilians, health care workers, ambulances and health facilities.
Since 13 April, more than 83 people have been killed and more than 1126 people injured across Khartoum, South Kordofan, North Darfur, Northern State and other regions, w...
Source: WHO EMRO News - April 16, 2023 Category: Middle East Health Source Type: news
Prophylactic Use of Tranexamic Acid Not Beneficial in Cesarean Delivery
THURSDAY, April 13, 2023 -- For patients undergoing cesarean delivery, prophylactic use of tranexamic acid does not lead to a lower risk for a composite of maternal death or blood transfusion, according to a study published in the April 13 issue of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 13, 2023 Category: Pharmaceuticals Source Type: news
Tranexamic Acid May Not Prevent Hemorrhage After C-Section
(MedPage Today) -- Prophylactic tranexamic acid (TXA) during cesarean delivery did not lead to a lower risk of maternal death or blood transfusion, a randomized trial found.
Among 11,000 women in 31 U.S. hospitals assigned to TXA or placebo after... (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - April 12, 2023 Category: OBGYN Source Type: news
Tunisia: Tunisia Needs 750 Blood Donors Daily to Cover Its Blood Needs
[Tunis Afrique Presse] Tunis/Tunisia -- The National Blood Transfusion Center, the Ministry of Health, and components of civil society supporting blood donation celebrated the National Blood Donation Day by honoring a group of donors at a ceremony held in the City of Culture in the capital. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 10, 2023 Category: African Health Source Type: news
